Medrx Co (TSE:4586) Dividend Payout Ratio : 0.00 (As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Medrx Co Dividend Payout Ratio?

Medrx Co's dividend payout ratio for the months ended in Mar. 2024 was 0.00.

The historical rank and industry rank for Medrx Co's Dividend Payout Ratio or its related term are showing as below:

TSE:4586's Dividend Payout Ratio is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.33
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-06-23), the Dividend Yield % of Medrx Co is 0.00%.

Medrx Co's Dividends per Share for the months ended in Mar. 2024 was 円0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Medrx Co Dividend Payout Ratio Historical Data

The historical data trend for Medrx Co's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medrx Co Dividend Payout Ratio Chart

Medrx Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dividend Payout Ratio

Get a 7-Day Free Trial

Medrx Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Dividend Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Medrx Co's Dividend Payout Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Medrx Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medrx Co's Dividend Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medrx Co's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Medrx Co's Dividend Payout Ratio falls into.

Medrx Co Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Medrx Co's Dividend Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Dec. 2023 )	/	EPS without NRI (A: Dec. 2023 )
	=	0	/	-26.832
	=	N/A

Medrx Co's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2024 )	/	EPS without NRI (Q: Mar. 2024 )
	=	0	/	-3.33
	=	N/A

Medrx Co (TSE:4586) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Medrx Co Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Medrx Co's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Medrx Co (TSE:4586) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medrx Co Ltd (TSE:4586) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

431-7 Nishiyama, Higashikagawa, Kagawa, JPN, 769-2712

Website

http://www.medrx.co.jp

Medrx Co Ltd is a pharmaceutical drug development company founded in January, 2002. The Company engaged in the research and development of pharmaceutical products utilizing the pharmaceutical formulation technology based on ionic liquid transdermal system. The Company develops new pharmaceutical candidates and licenses other companies to produce the pharmaceuticals after clinical trials. Its main products include analgesic patches for anti-inflammatory and pain relief.

Medrx Co (TSE:4586) Headlines

No Headlines